Navigation Links
Lorillard Tobacco Company Comments on Harvard School of Public Health Report
Date:7/16/2008

GREENSBORO, N.C., July 16 /PRNewswire/ -- While Lorillard Tobacco Company (a wholly-owned subsidiary of Lorillard, Inc. (NYSE: LO)) has not yet had the opportunity to fully review the latest report from the Harvard School of Public Health, the company is gratified that the report reaffirms its view with respect to the present state of the science examining menthol use in cigarettes, including that:

-- "The available [scientific] evidence remains inconclusive" that menthol cigarettes confer a higher risk than non-mentholated cigarettes for smoking-related diseases.

-- "Recent studies did not find significant differences in risk for disease between menthol and non-menthol smokers."

-- "Research on differences in cessation outcomes between menthol and non-menthol smokers had conflicting results."

However the report's conclusion that Lorillard controls or alters the menthol levels in its products to promote smoking initiation or addiction is categorically false.

Lorillard does not control levels of menthol to promote smoking among adolescents and young adults. Furthermore, Lorillard does not engineer any of its cigarettes to promote smoking initiation or nicotine addiction. Importantly, the target menthol specifications for Newport have not changed at all since 2000.

Lorillard is in the business of manufacturing cigarettes for sale to adult smokers. The company wants every adult smoker who prefers menthol cigarettes to choose its Newport product. This is why Lorillard strives to make a product with superior taste and consistency.

The company also rejects the report's conclusion that Lorillard targets youth smokers. The authors should know that pursuant to an agreement with the state's Attorneys General, Lorillard does not advertise in magazines that have a youth readership of 15 percent or greater and/or a circulation of two million or more readers under 18 years of age. This is not a new policy and has been in effect for years. Contrary to the report's assertion, while the magazine advertising expenditures for Newport may fluctuate from year to year, overall spending on magazine advertising has decreased over the last 10 years.

About Lorillard, Inc.

Lorillard, Inc. (NYSE: LO), the parent company of Lorillard Tobacco Company, is the third largest manufacturer of cigarettes in the United States. Lorillard was founded in 1760, and is the oldest continuously operating tobacco company in the U.S. Newport(R), Lorillard's flagship brand, is a menthol-flavored premium cigarette brand and the top selling menthol and second largest selling cigarette in the U.S. In addition to Newport, the

Lorillard product line has five additional brand families marketed under the Kent(R), True(R), Maverick(R), Old Gold(R) and Max(R) brand names. These six brands include 44 different product offerings which vary in price, taste, flavor, length and packaging. Lorillard's manufactures all of its products at its Greensboro, North Carolina facility and maintains its headquarters there.

Forward-Looking Statements

Certain statements made in this press release are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, or the Reform Act. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain the words "expect", "intend", "plan", "anticipate", "estimate", "believe", "will be", "will continue", "will likely result", and similar expressions. In addition, any statement that may be provided by management concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible actions by Lorillard, Inc. are also forward-looking statements as defined by the Reform Act.

Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond the control of Lorillard, Inc., that could cause actual results to differ materially from those anticipated or projected. Information describing factors that could cause actual results to differ materially from those in forward-looking statements is available in Lorillard, Inc.'s filings with the Securities and Exchange Commission. These filings are available from the SEC over the Internet or in hard copy, and are, in some cases, available from Lorillard, Inc. as well. Forward-looking statements speak only as of the time they are made, and Lorillard, Inc. expressly disclaims any obligation or undertaking to update these statements to reflect any change in expectations or beliefs or any change in events, conditions or circumstances on which any forward-looking statement is based.

Contact:

Michael W. Robinson

202-973-1340

mrobinson@levick.com


'/>"/>
SOURCE Lorillard Tobacco Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from Lorillard Tobacco on FDA-Tobacco Regulation Legislation
2. FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Go Further by Giving FDA Authority Over Tobacco Products
3. Smokeless Tobacco Products Do Raise Cancer Risk
4. Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest
5. Rivalry Aside, Marlins and Rays Team Up To Fight Tobacco
6. Major Associations Band Together to Urge Congressional Action on Tobacco Legislation
7. Smokeless Tobacco: Not a Harmless Substitute
8. World No Tobacco Day Sounds Urgent Call for Nations to Fight Tobacco Use, Save Lives
9. PA State Health Officials Encourage Smokers to Quit on World No Tobacco Day
10. A new way to look at lung cancer and tobacco carcinogens
11. World No Tobacco Day: Global Organizations Join Forces To Break the Tobacco Marketing Net and Help Children Grow Up Smoke-Free
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: